Adamis Pharmaceuticals OverviewAdamis Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for ADMP.
Quarterly Other Income/Expense
$3.61M
As of Sep 30, 2023
Annual Other Income/Expense (TTM)
-$1.17M
Trailing 12 months ending Sep 30, 2023